5/24/2019  5:30:51 PM Chg. -3.40 Volume Bid5:32:58 PM Ask5:49:15 PM Market Capitalization Dividend Y. P/E Ratio
219.20CHF -1.53% 222,286
Turnover: 48.02 mill.
224.50Bid Size: 100 222.00Ask Size: 130 14.32 bill.CHF 1.19% 35.76

Business description

Sonova, headquartered in Stäfa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the Group is currently present in over 100 countries across the globe. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
 

Management board & Supervisory board

CEO
Arnd Kaldowski
Management board
Hartwig Grevener, Andi Vonlanthen, Christophe Fond, Claude Diversi, Claudio Bartesaghi, Ludger Althoff, Martin Grieder, Victoria E. Carr-Brendel
Supervisory board
Robert F. Spoerry, Dr. Beat Hess, Anssi Vanjoki, Dr. Michael Jacobi, Jinlong Wang, Lukas Braunschweiler, Lynn Dorsey Bleil, Ronald van der Vis, Stacy Enxing Seng
 

Company data

Name: Sonova Holding AG
Address: Laubisrütistraße 28,CH-8712 Stäfa
Phone: +41-58-928-0101
Fax: +41-58-928-2011
E-mail: info@sonova.com
Internet: www.sonova.com
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 3/31
Free Float: 61.68%
IPO date: -

Investor relations

Name: Thomas Bernhardsgrütter
IR phone: +41-58-928-3344
IR-Fax: +41-58-928-3399
IR e-mail: ir@sonova.com

Company calendar

CW 24 | 6/13/2019 General Shareholder Meeting
CW 25 | 6/17/2019 Ex-Dividend
CW 25 | 6/19/2019 Dividend Payment
CW 47 | 11/20/2019 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Freefloat
 
61.68%
Beda Diethelm
 
10.19%
Chase Nominees Ltd.
 
9.04%
Nortrust Nominees Ltd.
 
5.82%
Familie Hans-Ueli Rihs
 
5.67%
Bank of New York Mellon Nominee
 
4.17%
Fidelity Funds
 
3.43%